Regenxbio (RGNX) Change in Acquisitions & Divestments (2016 - 2025)
Regenxbio has reported Change in Acquisitions & Divestments over the past 10 years, most recently at $100.9 million for Q4 2025.
- Quarterly results put Change in Acquisitions & Divestments at $100.9 million for Q4 2025, up 94.73% from a year ago — trailing twelve months through Dec 2025 was $319.1 million (up 9.95% YoY), and the annual figure for FY2025 was $319.1 million, up 9.95%.
- Change in Acquisitions & Divestments for Q4 2025 was $100.9 million at Regenxbio, up from $82.2 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for RGNX hit a ceiling of $107.6 million in Q2 2023 and a floor of -$158.5 million in Q4 2022.
- Median Change in Acquisitions & Divestments over the past 5 years was $60.6 million (2023), compared with a mean of $45.0 million.
- Biggest five-year swings in Change in Acquisitions & Divestments: tumbled 566125.0% in 2022 and later surged 190.55% in 2023.
- Regenxbio's Change in Acquisitions & Divestments stood at $28000.0 in 2021, then tumbled by 566125.0% to -$158.5 million in 2022, then soared by 133.91% to $53.7 million in 2023, then decreased by 3.62% to $51.8 million in 2024, then skyrocketed by 94.73% to $100.9 million in 2025.
- The last three reported values for Change in Acquisitions & Divestments were $100.9 million (Q4 2025), $82.2 million (Q3 2025), and $71.1 million (Q2 2025) per Business Quant data.